Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by HC Wainwright to Sell
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by equities researchers at HC Wainwright from a “neutral” rating to a “sell” rating in a report issued on Monday, MarketBeat Ratings reports. Several other research analysts have also weighed in on the stock. Morgan Stanley reduced their price objective on shares of Sarepta Therapeutics from […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by equities researchers at HC Wainwright from a “neutral” rating to a “sell” rating in a report issued on Monday, MarketBeat Ratings reports. Several other research analysts have also weighed in on the stock. Morgan Stanley reduced their price objective on shares of Sarepta Therapeutics from […]
